News

The provision, part of the Senate budget bill, was described as “a blatant giveaway to the pharmaceutical industry that would keep drug prices high for patients while draining $5 billion in taxpayer ...
The pharmaceutical industry’s lobbying muscle scored a high-stakes victory on Monday when the Senate parliamentarian reversed a previous decision and ruled that the Optimizing Research Progress Hope ...
Diversified Trust Co increased its stake in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 7.8% in the 1st quarter, HoldingsChannel.com reports. The firm owned 6,069 shares of the company’s stock after ...
Despite major advances, real-world data show diminishing survival outcomes and treatment-limiting toxicities in second line ...
Zanubrutinib shows superior progression-free survival in chronic lymphocytic leukemia compared with acalabrutinib plus ...
AstraZeneca (AZ) has announced that its fixed-duration Calquence (acalabrutinib)-based regimens have been approved by the European Commission (EC) to treat chronic lymphocytic leukaemia (CLL) in the ...
The biomarkers and diagnostics field continues to boom, driven by advancements in genomic profiling, omics, and AI technologies. Uniting over 600 industry experts this September 22-25, the 15 th World ...
Calquence (acalabrutinib) is a prescription oral tablet that treats certain blood cancers in adults. Learn about dosage, side effects, and more.
Calquence is not currently approved for the treatment of MCL in Japan. As part of an extensive clinical development programme, Calquence is currently being evaluated as a single treatment and in ...
Calquence plus chemoimmunotherapy recommended for approval in the EU by CHMP as first and only BTK inhibitor for 1st-line mantle cell lymphoma Recommendation based on ECHO Phase III trial results ...
Calquence is not currently approved for the treatment of MCL in Japan. As part of an extensive clinical development programme, Calquence is currently being evaluated as a single treatment and in ...
Calquence (acalabrutinib) is a brand-name oral tablet prescribed for certain cancers in adults. Calquence has interactions with some other drugs and certain supplements. Examples include certain ...